Ciprofloxacin therapy for Mediterranean spotted fever

Antimicrob Agents Chemother. 1986 Oct;30(4):606-7. doi: 10.1128/AAC.30.4.606.

Abstract

We report the treatment of five patients with Mediterranean spotted fever with the antimicrobial agent ciprofloxacin. The treatment was administered intravenously for 2 days and then perorally for 8 days. All five patients were cured. These preliminary data seem to correlate with the in vitro activity of ciprofloxacin against Rickettsia conorii.

MeSH terms

  • Adult
  • Boutonneuse Fever / drug therapy*
  • Ciprofloxacin / blood
  • Ciprofloxacin / therapeutic use*
  • Female
  • Humans
  • Male

Substances

  • Ciprofloxacin